ArticleInternational journal of retina and vitreous2026
Targeting vision-threatening disease in EyeArt-based diabetic retinopathy screening
Article in International journal of retina and vitreous, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guedes et al. demonstrate excellent agreement between EyeArt and ophthalmologist grading for any diabetic retinopathy (DR) within a regional screening program, with near-perfect binocular sensitivity and high specificity. Building on these findings, this letter argues that screening programs are primarily justified by the prevention of vision-threatening DR (vtDR), and that performance metrics should therefore prioritize vtDR rather than any DR as the primary endpoint. The letter highlights how the current operating point, optimized for any DR, may not reflect an optimal balance between sensitivity, specificity, and downstream referral burden in real-world workflows. It also discusses how the study’s OCT-based risk factors support the development of multimodal and risk-integrated AI systems that combine fundus imaging, OCT, and clinical variables to triage vtDR more efficiently and personalize screening intervals.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.